文献速递其他结缔组织病系统性红斑狼疮血管炎

结缔组织病相关肺动脉高压的流行病学与死亡率:台湾全国队列研究

Epidemiology and mortality of connective tissue disease-associated pulmonary arterial hypertension: A national cohort study in taiwan.
PubMed 文献 · Semin Arthritis Rheum · 2020-06-16

该研究利用台湾全民健康保险数据库,纳入2002至2013年新发系统性硬化症、系统性红斑狼疮、原发性干燥综合征、多发性肌炎/皮肌炎和类风湿关节炎患者,计算肺动脉高压累积发病率及诊断后生存概率。结果显示系统性红斑狼疮是结缔组织病相关肺动脉高压中最常见基础病,但系统性硬化症患者发病风险最高且生存率最差。

要点

  • 系统性硬化症患者肺动脉高压发生率为7.68%,系统性红斑狼疮为2.06%。
  • 结缔组织病相关肺动脉高压患者中系统性红斑狼疮占57%,系统性硬化症占30%。
  • 系统性硬化症相关肺动脉高压5年生存率61.9%,低于系统性红斑狼疮相关(69.4%)和干燥综合征相关(80.6%)。

核心结论

  • 系统性红斑狼疮是结缔组织病相关肺动脉高压总体人群中最常见基础病,但系统性硬化症患者发生肺动脉高压风险最高且生存率最差。

研究设计与样本

  • 基于台湾全民健康保险数据库的全国队列研究,纳入2002至2013年新发系统性硬化症1653例、系统性红斑狼疮11735例、原发性干燥综合征17316例、多发性肌炎/皮肌炎1811例和类风湿关节炎32296例。

主要发现

  • 系统性硬化症患者肺动脉高压发生率为7.68%(127/1653),系统性红斑狼疮为2.06%(242/11735),原发性干燥综合征为0.22%(38/17316),多发性肌炎/皮肌炎为0.33%(6/1811),类风湿关节炎为0.04%(15/32296)。
  • 全部结缔组织病相关肺动脉高压患者中,系统性红斑狼疮占57%,系统性硬化症占30%,原发性干燥综合征占9%,类风湿关节炎占3%,多发性肌炎/皮肌炎占1%。
  • 系统性硬化症相关肺动脉高压1年、3年、5年生存率分别为88.3%、72.1%、61.9%;系统性红斑狼疮相关分别为87.6%、75.8%、69.4%;原发性干燥综合征相关分别为90.8%、86.8%、80.6%。

临床怎么用

  • 对系统性硬化症患者应高度警惕肺动脉高压发生,因其发病率最高且生存率最差,需早期筛查和监测。
  • 系统性红斑狼疮患者是结缔组织病相关肺动脉高压最常见人群,临床随访中亦需关注肺动脉高压筛查。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To estimate and compare the incidence and survival impact of pulmonary arterial hypertension (PAH) among patients with various connective tissue diseases (CTDs). METHODS: We used a national health insurance database in Taiwan and enrolled patients with incident systemic sclerosis (SSc), systemic lupus erythematosus (SLE), primary Sjögren's syndrome (pSS), polymyositis/dermatomyositis (PM/DM) and rheumatoid arthritis (RA) between 2002 and 2013. We calculated the cumulative incidence of PAH and the probability of survival after PAH diagnosis by the Kaplan-Meier method. RESULTS: Of 1653 SSc patients, 127 (7.68%) developed PAH. Of 11,735 SLE patients, 242 (2.06%) developed PAH. Of 17,316 pSS patients, 1811 PM/DM patients, and 32,296 RA patients, 38 (0.22%), 6 (0.33%) and 15 (0.04%) patients developed PAH, respectively. The most common CTD among all CTD-PAH patients was SLE (57%), followed by SSc (30%), pSS (9%), RA (3%) and PM/DM (1%). The 1-, 3- and 5-year survival rates for SSc-PAH were 88.3%, 72.1% and 61.9%, respectively. The 1-, 3- and 5-year survival rates for SLE-PAH were 87.6%, 75.8% and 69.4%, respectively. The 1-, 3- and 5-year survival rates for pSS-PAH were 90.8%, 86.8% and 80.6%, respectively. CONCLUSIONS: SLE was the most common underlying CTD, followed by SSc, in the total CTD-PAH population. However, the highest risk of developing PAH was observed in the SSc groups. PAH is a very rare complication in pSS, PM/DM and RA. Patients with SSc-PAH have the worst survival rate compared to those with SLE-PAH or pSS-PAH.

来源:Semin Arthritis Rheum,查看原文。版权归原作者所有。

引用

  1. Lin CY, Ko CH, Hsu CY, et al. Epidemiology and mortality of connective tissue disease-associated pulmonary arterial hypertension: A national cohort study in taiwan. Semin Arthritis Rheum. 2020. PMID: 32906031. doi:10.1016/j.semarthrit.2020.06.005

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。